News Image

Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device

Provided By GlobeNewswire

Last update: Nov 1, 2024

The Acclaim® Fully Implanted Cochlear Implant is differentiated from existing cochlear implants and may offer new option for hearing loss patients

Read more at globenewswire.com

ENVOY MEDICAL INC

NASDAQ:COCH (2/21/2025, 8:10:29 PM)

1.48

-0.04 (-2.89%)



Find more stocks in the Stock Screener

Follow ChartMill for more